BLFS Stock Analysis: Buy, Sell, or Hold?
BLFS - BioLife Solutions Inc.
$21.80
-0.78 (-3.45%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 02, 2026
28d
Get Alerted When BLFS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BLFS is down 12.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BLFS is down 12.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BLFS is currently trading at $21.80, which is considered oversold relative to its 30-day fair value range of $23.58 to $25.58. From a valuation perspective, the stock is trading at a discount (Forward PE: 136.2) compared to its historical average (169.1). Remarkably, the market is currently pricing in an annual earnings decline of 6.9% over the next few years. This pessimistic expectation contrasts with the company's recent 640.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BLFS is in a downtrend. The price is currently testing key support at $21.78. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: BLFS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.44 (+48.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BLFS is in a downtrend. The price is currently testing key support at $21.78. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: BLFS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $32.44 (+48.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$23.58 -
$25.58
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
61.5%
Protect Your Profits
Holding BLFS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.5%)
- BULLISH: Trading 48.8% below Wall St target ($32.44)
- WARNING: Recommendation downgraded due to -12.3% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$23.58 -
$25.58
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.83
(8.4%)
Support & Resistance Levels
Support Level
$21.78
Resistance Level
$26.54
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
136.25
Wall Street Target
$32.44
(+48.8%)
Revenue Growth (YoY)
31.2%
Earnings Growth (YoY)
640.0%
Profit Margin
-3.2%
Valuation Discount vs History
-6.9% cheaper
PE vs Historical
136.3 vs 169.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.9%
(market-implied from PE analysis)
1-Year Target
$20.30
(-7%)
2-Year Target
$18.90
(-13%)
3-Year Target
$17.59
(-19%)
3-Yr Target (if PE normalizes)
(PE: 136→169)
$21.83
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 136.2, Growth: 100.0%)
$73.58
(+238%)
Base:
(SPY PE: 22.3, Growth: 100.0%)
$12.04
(-45%)
Bear:
(PE: 19.0, Growth: 100.0%)
$10.24
(-53%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 136.2 to 169.1
Stabilization Target:
$27.06
(+24.1%)
PE Expansion Potential:
+24.1%
Last updated: February 01, 2026 4:08 AM ET
Data refreshes hourly during market hours. Next update: 5:08 AM
Data refreshes hourly during market hours. Next update: 5:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLFS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Sean Werner
SELL
275 shares
2025-10-20
Casdin Partners Master F…
SELL
750000 shares
2025-10-15
Aby J Mathew
SELL
509 shares
2025-10-09
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced BLFS Option Strategies
Professional options setups generated by AI based on today's BLFS price and gamma walls.
